Complete the form to instantly download the CeleCor Backgrounder


    *Indicates required field

    About Us

    We founded CeleCor Therapeutics to improve the treatment of ST-segment elevation myocardial infarctions (STEMI heart attacks) at the first point of medical contact.

    Founders & Board of Directors

    Barry Coller, MD

    Chair, Medical & SAB, Co-Founder, and Inventor of RUC-4

    Barry S. Coller, MD, is vice president for medical affairs, David Rockefeller Professor, head of the Allen and Frances Adler Laboratory of Blood and Vascular Biology, and physician-in-chief at The Rockefeller University. He is an expert on the basic molecular mechanisms involved in blood clotting and thrombosis. His research accomplishments include the development of a monoclonal antibody to platelets that was developed into the drug ReoPro. He is also the inventor of RUC-4.

    Read More

    Robert Hillman, PhD

    President & CEO, Co-Founder

    Robert S. Hillman, PhD, is a biomedical engineer and successful serial entrepreneur/inventor. He studied at Stanford University, MIT, and the Swiss Federal Institute of Technology (ETH-Z). Early in his career, Dr. Hillman led the development of the GenESA System, the first drug-device combination cleared by the FDA for diagnosing coronary artery disease. Dr. Hillman was also co-founder at Accumetrics, where he led the development of the VerifyNow System; Biotrack, where he lead the development of the CoaguCheck System; Tem Systems, where he led the development of the Rotem Sigma; and ActivX Biosciences, an early pioneer in activity-based proteomics. Many of these products are still in use today in hospitals and research institutions worldwide.

    Read More

    Andreas Ritzi

    Co-Founder; Member, Board of Directors

    Andreas Ritzi is CFO of Cadorit AG, a Swiss-based investment company. He is a financial specialist and accomplished entrepreneur. He has an MBA from the University of St. Gallen and an MSc in Finance from the London Business School.

    Read More

    Jack Lief

    Member, Board of Directors

    Jack Lief co-founded Arena Pharmaceuticals, Inc. and served as its president and chief executive officer. He served as chairman of the board of directors of BIOCOM and is an executive board member of BIOCOM. He also held senior business development positions at Cephalon, Alpha Therapeutics and Abbott Laboratories.

    Read More

    Company & Advisors

    Oana Cociorva, PhD

    Sr. Director of Planning and Administration

    MariJo Gleeson

    Chief Financial Officer

    Lynda Szczech, MD

    Medical Monitor, Clinical Development

    Yatindra Joshi, PhD

    Pharmaceutical Development

    Ellis F. Unger, MD

    Principal Drug Regulatory Expert, Hyman, Phelps & McNamara, P.C.

    Peter Finn

    Corporate Counsel & Counsel to BOD

    Arnoud van't Hof

    Principal Investigator, Member Steering Committee

    C. Michael Gibson, MD

    Chairman, Steering Committee

    Michael Levy, MD

    Steering Committee

    Chris Granger, MD

    Steering Committee

    Gilles Montalescot, MD

    Steering Committee

    Jur ten Berg, MD

    Steering Committee

    John Maraganore, PhD

    Strategic Advisor

    Andrew Weisenfeld

    MTS Partners, Strategic & Financial Advisor

    Sooin Kwon

    MTS Partners, Strategic & Financial Advisor

    Martin Gerstel

    Business Advisor

    Jesse Dylan

    Wondros, Strategic Advisor
    1155 Camino Del Mar Suite 481,
    Del Mar, CA, 92014

    Contact Us